SV2A and epilepsy: Because SV2A KO mice display spontaneous and violent seizures, and as the anti-epileptic drug Levetiracetam (LEV—also known as Keppra©) targets SV2A (Lynch et al., 2004), many studies have addressed the possible role(s) of SV2A in various pathological conditions, particularly in epilepsy pathophysiology.